NDC properties for "adalimumab-aaty 40 MG per 0.4 ML Auto-Injector" (RxCUI 2639651)
About this data
The tables show NDC propoerties for adalimumab-aaty 40 MG per 0.4 ML Auto-Injector with the RxCUI 2639651
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-aaty 40 MG per 0.4 ML Auto-Injector (RxCUI 2639651)
| BLA | BLA761219 |
|---|---|
| MMSL_CODE | MTH_RXN_BD39482 |
| RxCUI | 2639651 |
| SPL_SET_ID | c44365e9-d470-4e35-978d-8565a9e3471e |
| VUID | 4042392 |
| Prescribable Synonym | adalimumab-aaty 40 MG in 0.4 ML Auto-Injector |
| RXNAV_STR | 0.4 ML adalimumab-aaty 100 MG/ML Auto-Injector |
| RxNorm Name | 0.4 ML adalimumab-aaty 100 MG/ML Auto-Injector |
| RxNorm Synonym | adalimumab-aaty 40 MG per 0.4 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2639651) |
NDC Properties
NDC Item 72606002209
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-09 |
| NDC Item | 72606002209 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-09) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002210
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-10 |
| NDC Item | 72606002210 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-10) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002211
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-11 |
| NDC Item | 72606002211 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-11) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002212
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-12 |
| NDC Item | 72606002212 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-12) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002209
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-09 |
| NDC Item | 72606002209 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-09) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002210
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-10 |
| NDC Item | 72606002210 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-10) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002211
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-11 |
| NDC Item | 72606002211 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-11) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002212
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-12 |
| NDC Item | 72606002212 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-12) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002209
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-09 |
| NDC Item | 72606002209 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-09) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002210
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-10 |
| NDC Item | 72606002210 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-10) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002211
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-11 |
| NDC Item | 72606002211 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-11) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002212
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-12 |
| NDC Item | 72606002212 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-12) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002209
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-09 |
| NDC Item | 72606002209 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-09) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002210
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-10 |
| NDC Item | 72606002210 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-10) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002211
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-11 |
| NDC Item | 72606002211 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-11) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002212
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-12 |
| NDC Item | 72606002212 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-12) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |